Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-09-10

Clinical Trial Update: Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating withdrawal of immunosuppression in long-term stable liver transplant recipients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Catholic University of Korea | Conditions: Liver Transplantation | Phase 2 | Status: UNKNOWN